The Vivos Therapeutics AireO2 patient management software is designed to help healthcare professionals more effectively diagnose, treat, and monitor patients with obstructive sleep apnea (OSA) and its related conditions.
Approximately a billion people suffer from OSA, according to the company, and up to 80% of people who have sleep apnea remain undiagnosed. Left untreated, OSA may increase the risk of high blood pressure and hypertension, heart failure, stroke, and other diseases.
Developed in collaboration with Lyon Dental, AireO2 includes features that enhance healthcare professionals’ billing services and more, Vivos Therapeutics said, including practice management systems.
“We believe that Vivos’ sleep-specific AireO2 patient management technology represents a significant advancement in how medical and dental professionals will be able to treat sleep disorders,” said Kirk Huntsman, Vivos’ chair and CEO.
“Sleep apnea is a serious chronic disease that impacts much more than just sleep. It impacts patients’ quality of life and overall health. With AireO2, we believe that we can make it significantly easier for sleep disorder healthcare providers to manage their growing caseloads and increase the number of patients whom they can treat on any given day,” Huntsman said.
“We look forward to continuing the launch of AireO2 as a complement to our existing Billing Intelligence Service for our Vivos Integrated Practices and to actively pursuing AireO2 as a revenue source from other OSA-focused healthcare providers,” Huntsman said.
“Vivos’ new technology has ultimately allowed me to see more patients and increase the quality of their care, all of the while boosting operational efficiency for my practice,” said dentist Dr. Lindsay Williams, who is part of the Vivos Integrated Practice program.
“Vivos’ innovative new platform can help the medical community as a whole to tackle this prevalent silent killer head-on in hopes of saving more lives and raising awareness of this deadly disease,” Williams said.
Related Articles
Combat Dental Problems by Treating Sleep Apnea Patients
Sleep Apnea May Be a COVID-19 Risk Factor
Obstructive Sleep Apnea Strains the Heart
